Effectiveness of Two Different Methods During Intramuscular Antibiotic Injection: ShotBlocker, Local Vibration
1 other identifier
interventional
105
1 country
1
Brief Summary
In intramuscular injection applications, which are among the responsibilities and basic skills of nurses, different methods are used to reduce the pain caused by injection and increase the individual's satisfaction. ShotBlocker and local vibration are among the methods used for this purpose. The aim of the study is to examine the effectiveness of ShotBlocker and local vibration, which are among the non-pharmacological methods, on the perceived pain and satisfaction during ventrogluteal intramuscular antibiotic injection. This randomized, controlled experimental study will be carried out in the adult emergency clinic of a training and research hospital in Istanbul between February and April 2021.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2021
CompletedFirst Posted
Study publicly available on registry
April 20, 2021
CompletedStudy Start
First participant enrolled
April 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedMarch 13, 2023
March 1, 2023
1 month
March 19, 2021
March 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Using ShotBlocker and local vibrator device during intramuscular antibiotic injection reduces the patient's injection related pain.
The change from baseline in pain scores will be measured immediately after intramuscular injection using Visual Analogue Scale (VAS) for pain. On a ten-centimetre long horizontal line, there are definitions of "no pain" at the left end and "unbearable pain" at the right end. High scores indicate a high level of pain.
The procedure will take a total of 10 minutes.
Using ShotBlocker and local vibrator device during intramuscular antibiotic injection increases the patient's injection related satisfaction.
The change from baseline in satisfaction scores will be measured immediately after intramuscular injection using Visual Analogue Scale (VAS) for satisfaction. On a ten-centimetre long vertical line, there is the statement "Strongly dissatisfied" at the lower end of the line, and "Strongly satisfied" at the upper end. High scores indicate a high level of satisfaction.
The procedure will take a total of 10 minutes.
Study Arms (3)
ShotBlocker
EXPERIMENTALShotBlocker will be used on 35 patients. For the patient group that is applied ShotBlocker, after cleansing the skin, the protruding surface of the device is placed facing the skin surface. The injection is applied with the appropriate technique, then ShotBlocker is removed and a light pressure is applied to the area with a cotton pad for 15-20 seconds.
Local Vibration
EXPERIMENTALLocal Vibration will be used on 35 patients. For the patient group that was subject to local vibration, local vibration was applied to the region with a vibrator for five minutes prior to injection, following a previous study on this subject. After that, 70% alcohol was used to cleanse the skin. The injection was applied with the appropriate technique, then a light pressure was applied to the area with a cotton pad for 15-20 seconds.
Control
NO INTERVENTIONFor the control group (n=35), IM injection into the ventrogluteal region without using any tools is performed with the appropriate technique.
Interventions
Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form". Application: ShotBlocker will be used on 35 patients during intramuscular injection. Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.
Intervention: Verbal information was given to the participants prior to the intramuscular injection, and their written consents were obtained. The "Structured Information Form" consisting of five questions was applied by face-to-face interview method. Height and weight were measured, and BMI (kg/m2) was calculated and recorded in the "Structured Information Form". Application: Local vibrator device will be used on 35 patients during intramuscular injection. Final assessment: VAS will be applied immediately after the intramuscular injection to determine the pain and satisfaction levels of the participants.
Eligibility Criteria
You may qualify if:
- Being over the age of 18, Having no communication problem such as seeing, hearing and understanding problem,
- Having no disease that can cause sensory loss,
- Not having had IM injection in the last week, Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic
Göztepe, Istanbul, 34035, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kurtuluş Açıksarı
Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic
- PRINCIPAL INVESTIGATOR
Alper Solakoğlu
Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Emergency Medicine Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The sample of the study consisted of volunteer patients who applied to the adult emergency service, and who were administered antibiotics (amoxicillin / cefuroxime sodium) upon the physician's request, and who met the inclusion criteria of the study. Criteria for inclusion in the study: * Being over the age of 18, * Having no communication problem such as seeing, hearing and understanding problem, * Having no disease that can cause sensory loss, * Not having had IM injection in the last week, * Having no complication related to IM injections such as pain, abscess, infection, tissue necrosis, and hematoma at the injection site.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 19, 2021
First Posted
April 20, 2021
Study Start
April 20, 2021
Primary Completion
May 30, 2021
Study Completion
May 30, 2021
Last Updated
March 13, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share